Dianthus Therapeutics is a clinical-stage biotechnology company pioneering novel monoclonal antibody treatments for severe autoimmune and inflammatory diseases. Our lead product, DNTH103, targets a specific part of the immune system and is designed for self-administration in some patients. We're making a significant impact in the biopharma industry by focusing on improved selectivity and potency, leading to more effective and targeted therapies. Our tech stack includes a robust mix of modern technologies such as Cloudflare JS, Google Cloud, and Cloudinary, reflecting our commitment to efficient and scalable development. We foster a collaborative engineering culture that embraces innovative approaches and prioritizes data-driven decision-making. We value scientific integrity, continuous learning, and a dedication to improving patient lives. We offer remote work opportunities and support a diverse and inclusive environment. Dianthus is a publicly traded company (NASDAQ: DNTH) with a strong funding history and a growing team of experienced professionals in biotech and pharma. We are actively expanding our team to support the advancement of DNTH103 through clinical trials and eventual commercialization. Join us in our mission to bring life-changing treatments to patients battling serious autoimmune diseases. We offer a supportive and flexible work environment which embraces remote work. Join our growing team and make a significant impact on the lives of patients suffering from autoimmune diseases. We are committed to providing transformative medicines for people living with severe autoimmune and inflammatory diseases.
📍 UK, EU, Nordic regions
🔍 Biotechnology
LeadershipProject ManagementResource PlanningCollaborationComplianceBudgetingQuality Assurance
📍 Europe
🔍 Biotechnology
LeadershipCross-functional Team LeadershipStrategyCommunication SkillsAnalytical SkillsCollaboration